Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.

about

Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.

Item

http://www.wikidata.org/entity/Q38717156

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential impact of nonavalent ...... d cervical cancer in Portugal.

@en

type

Item

label

Potential impact of nonavalent ...... d cervical cancer in Portugal.

@en

prefLabel

Potential impact of nonavalent ...... d cervical cancer in Portugal.

@en

P1476

Potential impact of nonavalent ...... d cervical cancer in Portugal.

@en

P2093

CLEOPATRE Portugal study group

http://www.w3.org/2001/XMLSchema#string

Carlos Freire de Oliveira

http://www.w3.org/2001/XMLSchema#string

Carlos Lopes

http://www.w3.org/2001/XMLSchema#string

Maria J Cunha

http://www.w3.org/2001/XMLSchema#string

P2860

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.

Global burden of human papillomavirus and related diseases.

Next generation prophylactic human papillomavirus vaccines.

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.

P304

90-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJGO.12243

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Angela Pista

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28632949

http://www.w3.org/2001/XMLSchema#string

P921

Portugal